Ethnopharmacological relevance Seven studied medicinal plants; Aconitum laciniatum, Ajania nubigena, Codonopsis bhutanica, Corydalis crispa, Corydalis dubia, Meconopsis simplicifolia and Pleurospermum amabile, are currently used in the Bhutanese Traditional Medicine (BTM) for the management of different types of disorders including the diseases that bore relevance to various inflammatory conditions.
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Aims of the study
This study aimed to evaluate the inhibition of TNF-α production in LPS-activated THP-1 monocytic cells by the crude extracts of seven selected Bhutanese medicinal plants. It is expected to: a) generate a scientific basis for their use in the BTM and b) form a basis for prioritization of the seven plants for further phytochemical and anti-inflammatory studies.
Materials and methods
Seven plants were selected using an ethno-directed bio-rational approach and their crude extracts were prepared using four different solvents (methanol, hexane, dichloromethane and chloroform). The TNF-α inhibitory activity of these extracts was determined by cytokinespecific sandwich quantitative enzyme-linked immunosorbent assays (ELISAs). The results were quantified statistically and the statistical significance were evaluated by GraphPad Prism version 5.01 using Student's t-test with one-tailed distribution. A p-value ≤ 0.05 was considered statistically significant.
Results
Of the seven plants studied, the crude extracts of six of them inhibited the production of proinflammatory cytokine, TNF-α in LPS-activated THP-1 monocytic cells. Amongst the six plants, C. crispa gave the best inhibitory activity followed by P. amabile, A. nubigena, C. dubia, M. simplicifolia and C. bhutanica . Of the 13 extracts that exhibited statistically significant TNF-α inhibitory activity (p<0.05; p<0.01), five of them showed very strong inhibition when compared to the DMSO control and RPMI media.
Conclusions
Six medicinal plants studied here showed promising TNF-α inhibitory activity. These findings rationalize the traditional use of these selected medicinal plants in the BTM as an individual plant or in combination with other ingredients for the treatment of disorders bearing relevance to the inflammatory conditions. The results forms a good preliminary basis for the
Introduction
One of the important mediators that regulates biochemical changes and the symptomatic pathophysiological responses in a body is a pro-inflammatory cytokine known as tumor necrosis factor alpha (TNF-α) which is produced by monocytes, macrophages and other types of cells. (Jang et al., 2004; Dey et al., 2008; Kang et al., 2009 ). Its over production by these cells causes a wide range of human diseases (Rose et al., 2005; Dey et al., 2008) . The inhibition of TNF-α in LPS activated THP-1 monocytic cells is generally used as an in vitro model for evaluating the anti-inflammatory effects of various materials including plant extracts. The plant extracts are known to exhibit various anti-inflammatory activities including the inhibition of the pro-inflammatory cytokine TNF-α. For example, the extract of a feverfew plant was found to effectively reduce LPS-mediated TNF-α and monocyte chemotactic protein-1 (MCP-1) released by THP-1 cells (Chen and Cheng, 2009) . Similarly, the ethanol extract of Cryptolepsis buchanani significantly inhibited TNF-α production in LPS-stimulated monocytic THP-1 cells (Laupattarakasem et al., 2006) . were prepared by mixing them with other ingredients and making them into pills, tablets, capsules and other dosage forms as reported in Wangchuk et al. (2011) . These plants contained different types of major classes of phytochemicals (established based on the TLC profile and phytochemical test protocols) and possess antimalarial, antimicrobial, antiTrypanosoma brucei rhodesiense and cytotoxicity effects (Wangchuk et al., 2011) .
However, no anti-inflammatory study have been carried out on these plants although their ethnopharmacological uses (see Table 1 ) bear relevance to various inflammatory conditions. For example, the common therapeutic indications of these medicinal plants (see Table 1 ) was for treating chin-tshad which is a traditional ethnomedical term used to describe fever associated with liver disorders. It is to be understood in the context of liver inflammation since it is characterized by tsha-ba (pain) with a rise in body temperature (Wangchuk et al., 2011) . Scientifically, liver inflammation occurs when the hepatic Kupffer cells (macrophages in the liver derived from monocyte) of the liver respond to foreign antigens by regulating the pro-inflammatory cytokine, TNF-α. Its over production can trigger the production of reactive oxygen species (ROS) and for this reason TNF-α has been implicated as a key mediator that plays an important role in inflammation and pathogenesis of many forms of liver diseases, often associated with fever.
Within these understandings, the crude extracts of the seven plants, with various therapeutic indications bearing relevance to the symptoms of inflammatory conditions, were subjected to screening for their inhibitory effects on the production of TNF-α cytokine in LPS-activated THP-1 monocytic cells. Through this study, it was expected to generate a scientific basis for their use in the BTM polyherbal formulations and also to find a basis for prioritization of the seven plants for our in-depth phytochemical and their anti-inflammatory studies in the future.
Materials and methods

Plant materials and preparation of crude extracts
Seven medicinal plants of Bhutan; A. laciniatum (Ranunculaceae), A.nubigena
(Fumariaceae), M. simplicifolia (Papaveraceae) and P. amabile (Umbelliferae) were selected based on the selection criteria described by Wangchuk et. al. (2011) . The ethnopharmacological uses of these plants (Phuntshok, 1994; Wangchuk et. al., 2011) are described in Table 1 . These selected plants were collected from Lingzhi within the altitudinal ranges of 2000 to 6000 metres above sea level in the period of June to December 2009.
Herbarium specimens were prepared and preserved at the Pharmaceutical and Research Unit (PRU) in Bhutan after assigning a voucher specimen number (see Table 1 ) (Wangchuk et al., 2011 ).
The dried plant material (2 kg) was chopped into small pieces and then repeatedly extracted with methanol over a period of four days to obtain the concentrated viscous methanol extracts of each plant (see Table 1 for their weights). A small portion of the crude methanol extract (10 g each) was then acidified with HCl (5%) and extracted with hexane and dichloromethane (5 x 60 mL of each solvent) to obtain their respective crude extracts ( Table   2 ). The remaining acidified aqueous solution was then basified (pH 9-11) with NH 4 OH solution and then extracted with CHCl 3 (5 × 60 mL) to yield the chloroform extracts of each plant (Table 2 ). Small portions of these different solvent crude extracts of each plant were then evaluated for their inhibitory effects on the TNF-α production in LPS-activated THP-1 monocytic cells. Weight of methanol extracts (in g) obtained from 2 kg of dried powdered materials.
2.2.Bioassay method
Based on the ethnopharmacological uses of the plants, the crude extracts of the seven Bhutanese medicinal plants were used to determine the inhibition of TNF-α production in LPS-activated THP-1 monocytic cells by in vitro bioassay method as detailed in Wangchuk et al. (2012a) . A total of 28 plant extracts (20 mg each), obtained using four different solvents (methanol, hexane, dichloromethane and chloroform) from the seven plants (Table 1) were used to determine inhibition of TNF-α production in LPS-activated THP-1 human monocytic cells. The hexane extract of C. dubia was not tested due to its poor solubility. All water extracts contained salts formed from the acid-base extraction process (see extraction methods above) and were therefore not tested.
The cell viability was studied for all the test samples and was determined from the ratio of viable cells over total cells. The percentage of cell viability was calculated by the formula:
% cell viability = 100 × (1−(dead cells ÷ total cells) and all the samples gave the % cell viability of ≥ 90%. TNF-α production in THP-1 cell culture supernatants were measured using the cytokine-specific sandwich quantitative enzyme-linked immunosorbent assays (ELISAs) according to the manufacturer's instructions (R & D Systems, USA). Absorbance was measured at 450 nM using a BioTek ® Synergy™ HT (Multi-Detection Microplate Reader, USA). A commercial anti-inflammatory drug, dexamethasone (1 µg/mL), (Atlantic LabsComp. Ltd., Thailand) was used as a positive control. The experiments were performed three times in triplicate (3x3). The percentage of TNF-α inhibition was calculated by the formula: % TNF-α inhibition = 100 × ((observed secreted TNF-α of experiment (pg/mL) ÷ baseline secreted TNF-α (DMSO) (pg/mL) − 1)). The statistical significance or differences were evaluated by GraphPad Prism version 5.01 using Student's t-test with one-tailed distribution. A p-value ≤ 0.05 was considered statistically significant.
Results and discussion
Usually, prior to the TNF-α bioassay, the concentration of test sample needs to be optimized through cell viability study and this optimization was carried out on one representative test sample, the MeOH extract of C. dubia in varying concentrations (0-200 µg/mL). At 50 µg/mL, there was no significant cell reduction/death and had the highest activity and thus, this dose/concentration was selected as the optimum concentration for determining the inhibitory activity of the other 27 crude extracts on TNF-α production in LPS-activated THP-1 cells. This further established that their inhibition of TNF-α production was not associated with the cytotoxic effects to THP-1 cells. In addition, the THP-1 cells in RPMI and THP-1 cells incubated with the crude plant extracts alone (without LPS) did not activate TNF-α production (data not shown) which established that their inhibition of TNF-α production was not associated with the cytotoxic effects to THP-1 cells. Usually, the secretion values of TNF-α of resting cells are very low at 0-<0.5 pg/mL. In the previous study where the cytotoxicity was determined on the normal Vero cells from kidney of African green monkey, Cecopithecus aethiops and the human oral carcinoma KB cells, only the chloroform extract of C. crispa was reported to exhibit moderate cytotoxicity against KB cells and rest of the crude extracts were found to be non-cytotoxic (Wangchuk et al., 2011) .
The results of the inhibition of TNF-α secretion and the percentage of TNF-α inhibition of the 27 crude extracts including that of reported C. crispa (for easy comparison) (Wangchuk et al., 2012a) by THP-1 monocytic cells is listed in Table 2 . In the presence of each of the plant extracts, TNF-α production was mostly inhibited and in a few cases, stimulated. Of the seven plants studied, the crude extracts of six of them inhibited the production of TNF-α cytokine with varying degrees and effects. Amongst the six plants, C. crispa gave the best inhibitory activity followed by P. amabile, A. nubigena, C. dubia, M. simplicifolia and C. bhutanica ( Table 2 ). The hexane and dichloromethane extracts of C. crispa (reported with pure compounds in Wangchuk et al., 2012a) displayed the most potent TNF-α inhibitory activity (see Table 2 ) by inhibiting/suppressing the TNF-α production to the level of 142 pg/mL (77% inhibition) and 71 pg/mL (89% inhibition), respectively.
Analysis of statistical significance or variances using Student's t-test with one-tailed distribution showed that these two crude extracts had the significance p-value of p<0.01
indicative of the content of good anti-TNF-α compounds. The in-depth phytochemical analysis of these crude extracts resulted in the isolation of nine alkaloids as protopine, 13-oxoprotopine, 13-oxocryptopine, stylopine, coreximine, rheagenine, ochrobirine, sibiricine and bicuculline (Wangchuk et al., 2012a) . Unlike its parent crude extracts, none of the tested pure alkaloids gave significant anti-TNF-α activities (Wangchuk et al., 2012a) which suggested that there must be some other minor or non-alkaloid components in the crude extracts responsible for the significant anti-TNF-α activities.
Similarly, the hexane and dichloromethane extracts of P. amabile showed significant TNF-α inhibitory activity with the production values of 206 pg/mL (67% inhibition) and 300 pg/mL (52% inhibition), respectively. The methanol and chloroform extracts of C. dubia displayed good TNF-α inhibitory activity with the suppression of TNF-α production to the level of 236 pg/mL (62% inhibition) and 258 pg/mL (58% inhibition), respectively. c positive control drug at 1 µg/ml concentration; *weight of crude solvent fraction/extracts (in mg) obtained from 10 g of crude MeOH extracts where NA for not applicable has been indicated; **secretion value of TNF-α of resting cells = 0-<0.5 pg/mL and the level of TNF-α production were determined for the optimized dose/concentration of 50 ug/mL of each solvent extracts of the plants;
† statistical significance (in relative to solvent control) was p<0.05; ‡ statistical significance with p<0.01; − : inhibited; +: activated; NT: Not tested.
RR reported results from Wangchuk et al. (2012a) .
In-depth phytochemical analysis identified seven isoquinoline alkaloids as scoulerine, cheilanthifoline, protopine, capnoidine, bicuculline, corydecumbine and hydrastine and they await testing for anti-TNF-α activities (Wangchuk et al., 2012b) . The dichloromethane extract of A. nubigena showed the TNF-α inhibitory value of 220 pg/mL (65% inhibition). A.
laciniatum did not inhibit the production of TNF-α cytokine but instead stimulated the production of TNF-α cytokine.
Segregating the activities by the level of statistical significance, of the total of 27 crude extracts obtained from seven plants, 13 of them inhibited the TNF-α production in LPSactivated THP-1 cells with the statistical significance of p<0.05 and p<0.01 (in comparison to DMSO solvent control and the RPMI culture media control) (see Table 2 for inhibition values). Of these 13 extracts, six of them inhibited the production of pro-inflammatory cytokine TNF-α with 58-89% percent inhibition which gave the statistical significance of p<0.01. Another seven extracts (out of 13) suppressed the production of pro-inflammatory cytokine TNF-α with 32-52% percent inhibition which gave the statistical significance of p<0.05. The positive control drug, dexamethasone (1 µg/mL), significantly inhibited the secretion/production of TNF-α at the values of 258 pg/mL (58% of inhibition) with the statistical significance of p<0.01.
We observed that, amongst the four different solvent extracts, the chloroform extract consistently showed the best TNF-α inhibitory activities (Table 2) closely followed by the dichloromethane and hexane. This indicated that chloroform was the best solvent for extracting the bioactive secondary metabolites from seven medicinal plants. Since the chloroform extracts contained basic components (see the extraction procedures), it may be also concluded that basic compounds are responsible for better biological activities.
Conclusion and future directions
Of the seven plants studied, the extracts of six of them exhibited TNF-α inhibitory activities with the highest being that of C. crispa (Wangchuk et al., 2012a) followed by P.
amabile, A. nubigena, C. dubia, M. simplicifolia and C. bhutanica. Thirteen extracts, obtained from the selected seven plants, significantly (p<0.05 and p<0.01) inhibited the production of TNF-α cytokine in LPS-activated THP-1 cells when compared to DMSO solvent control and the RPMI culture media control which indicated that these crude extracts possess compounds with promising anti-inflammatory properties. Thus, our study forms a good preliminary basis for the prioritization of candidate plant species for further in-depth phytochemical and antiinflammatory investigations which will be carried out. When in-depth investigation of an individual plant will be studied, it would be worthwhile to assess the anti-inflammatory potency of these medicinal plants on other inflammatory parameters as well as determine their IC 50 values both on in vitro and in vivo models.
This study also generated, for the first time, the preliminary scientific basis for the traditional use of these seven medicinal plants in the BTM for the treatment of various disorders related to inflammation. None of the crude extracts studied here were found to be cytotoxic to the human monocytic cell line, THP-1 and therefore further research with these potential crude extracts could: a) elucidate new mechanism of action of the plants, b) generate new anti-inflammatory compounds, and c) ultimately open up new vista in the management of inflammatory disorders especially in Bhutan.
